Physician profile
Thomas Florack
NPI 1649296518
$4,577.66
in general payments reported to CMS, 2019-2025
9 companies · $1,678 in 2025
The $1,678 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $112 · 2022: $119 · 2023: $1,019 · 2024: $1,060 · 2025: $1,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,560 · Food and Beverage: $1,101 · Education: $96.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,559.86 |
| Food and Beverage | $1,100.80 |
| Education | $96.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,354.65 | 2020-2025 | Rosa, Persona, Osseofit |
| Stryker Corporation | $844.64 | 2019-2025 | Blueprint Patient Specific Instrumentation |
| Depuy Synthes Sales INC. | $229.38 | 2023-2025 | Na, Va-Lcp, Fibergraft Aeridyan Matrix |
| Heron Therapeutics, INC. | $65.74 | 2023 | Zynrelef |
| Ethicon US, LLC | $24.02 | 2024 | Vistaseal, Stratafix, Ethicon |
| Avanos Medical | $19.76 | 2019 | |
| Sonex Health, INC. | $15.11 | 2024 | Sx-One Microknife |
| Integra Lifesciences Corporation | $13.18 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Endo Pharmaceuticals INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Florack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.